HIV / AIDS in the News

Study finds preventive HIV drugs are under prescribed to young women at increased risk - Medical Xpress

 

New Clues to Understanding HIV-Related Cognitive Impairment - POZ

 

Tiny doses of THC show big benefits for HIV treatment - ScienceDaily

 

Tiny doses of THC show big benefits for HIV treatment - ScienceDaily

 

Gilead’s Yeztugo Approval Highlights HIV Growth And Acquisition-Fueled Upside - simplywall.st

 

HIV advocates rally against changes to AIDS drug assistance program at Florida State Capitol - wtxl.com

 

Global health strains under US aid cuts - China Daily - Global Edition

 

Two New HIV Fundraising Bike Rides Take Off in California - POZ

 

HIV Sample Collection Kit Vendors Face FDA Warnings - Citeline News & Insights

 

HIV Sample Collection Kit Vendors Face FDA Warnings - Citeline News & Insights

 

[Press release] Kazan Federal University: International team sheds light on severe cases of COVID-19 infection in patients with HIV - European AIDS Treatment Group

 

Drag Race's Mandy Mango enters a new era as advocate for HIV care - Yahoo

 

Foreign National Declares Wanting to Spread HIV in the Philippines Stirs Concern Among Netizens - International Business Times

 

Florida to cut $120 million from AIDS drug assistance program - wctv.tv

 

Shionogi Acquires $2.1 Billion ViiV Healthcare Shareholdings from Pfizer - PharmExec.com

 

Ron DeSantis will have 'blood on his hands' if HIV funding isn't restored, Democratic chair says - Advocate.com

 

Health Policy Watch: One year later: The effect of US ‘chainsaw’ on global health - European AIDS Treatment Group

 

aidsmap: Scale-up of online HIV and STI self-sampling hasn’t led to more equitable outcomes in England - European AIDS Treatment Group

 

Patch That Automatically Detects HIV Infections - thecolu.mn

 

Bioengineering: HIV-related liver disease: A new era emerges - European AIDS Treatment Group

 

Pfizer sells its stake in GSK's ViiV for $1.9B, with Shionogi upping its ante in the HIV-focused company - Fierce Pharma

 

Adolescents report a preference for long-acting injectable HIV therapy - Contemporary Pediatrics

 

The near death -- and last-minute reprieve -- of a trial for an HIV vaccine - GBH

 

Eurasianet: A year on, USAID cuts leave gap in Central Asia’s fight against TB, HIV - European AIDS Treatment Group

 

[Press release] Texas Biomedical Research Institute: TB and HIV treatments are not enough for a full recovery - European AIDS Treatment Group

 

Medscape: Bictegravir combo shows promise in HIV-TB coinfection - European AIDS Treatment Group

 

Pfizer sells ViiV stake to Shionogi - The Pharma Letter

 

CVS Health agrees to cover new HIV prevention drug - Washington Blade

 

ViiV ownership shifts as Pfizer sells its stake - pharmaphorum

 

Iraq blames overseas travel and tattoos for rise in HIV cases - The New Arab